<DOC>
	<DOC>NCT01589822</DOC>
	<brief_summary>The purpose of this study is to evaluate the safety and effectiveness of EVICEL® Fibrin Sealant (Human) for use as an adjunct to gastrointestinal (GI) surgery.</brief_summary>
	<brief_title>The EVICEL® Gastrointestinal Study</brief_title>
	<detailed_description>This is a single blind, randomized, multi-center controlled study evaluating the safety and effectiveness of EVICEL® when used as an adjunct to gastrointestinal (GI) surgery.</detailed_description>
	<mesh_term>Gastrointestinal Diseases</mesh_term>
	<mesh_term>Digestive System Diseases</mesh_term>
	<mesh_term>Fibrin Tissue Adhesive</mesh_term>
	<criteria>Subjects undergoing primary elective GI surgery Subjects ≥ 18 years of age who are willing to participate in the study and provide written informed consent prior to any studyrelated procedures Avastin use within 30 days prior to surgery; Known hypersensitivity to the human blood products or the components of the investigational product; Female subjects who are pregnant or nursing; Exposure to another investigational drug or device in a clinical trial within 30 days prior to surgery or planned/intended for the 90 day follow up period after surgery.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>